Sort
48,018 grants matching “immunotherapy”
Development of a platform for spatial functional genomics
$723,980Brian D Brown · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AT
Development of a platform for spatial functional genomics
$723,980Brian D Brown · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · AT
Redox Mechanism Process of Angiogenesis and Wound Healing
$723,973David Wink · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Therapy of Dengue with Modified Antibodies in Humanized Mice
$723,876Rebeca Rico-Hesse · Baylor College Of Medicine · R01 · FY2014 · AI
Southeast Pediatric AIDS Clinical Trials Unit
$723,865University Of Alabama At Birmingham · U01 · FY2003 · AI
Visualization hub for genomics data exploration and translational discovery
$723,803Jingchun Zhu · University Of California Santa Cruz · U24 · FY2019 · CA
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$723,466Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Quantitative Endogenous MRI Imaging of Neuroinflammation in AD
$723,436Qing Wang · Washington University · R01 · FY2024 · AG
Immune determinants of progression from Oral Epithelial Dysplasia to Oral Squamous Cell Carcinoma by precision multiplexed imaging
$723,279Matthew Spitzer · University Of California, San Francisco · R01 · FY2024 · DE
Biology of α-linked glycosylceramides in the immune system
$723,259Luc Teyton · Scripps Research Institute, The · R01 · FY2020 · AI
Biology of α-linked glycosylceramides in the immune system
$723,259Luc Teyton · Scripps Research Institute, The · R01 · FY2019 · AI
Biology of α-linked glycosylceramides in the immune system
$723,259Luc Teyton · Scripps Research Institute, The · R01 · FY2021 · AI
Biology of α-linked glycosylceramides in the immune system
$723,259Luc Teyton · Scripps Research Institute, The · R01 · FY2018 · AI
A Phase 1 Study to Evaluate Chimeric Antigen Receptor (CAR) T cells Targeting TAG72 in Patients with Recurrent Epithelial Ovarian Cancer
$723,036Saul Priceman · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Macromolecular Conformational Heterogeneity
$722,975Alexander D. Mackerell · University Of Maryland Baltimore · R35 · FY2023 · GM
Macromolecular Conformational Heterogeneity
$722,975Alexander D. Mackerell · University Of Maryland Baltimore · R35 · FY2021 · GM
Macromolecular Conformational Heterogeneity
$722,975Alexander D. Mackerell · University Of Maryland Baltimore · R35 · FY2022 · GM
Macromolecular Conformational Heterogeneity
$722,975Alexander D. Mackerell · University Of Maryland Baltimore · R35 · FY2020 · GM
Quantitative and Spatially-Resolved Analysis of the Tumor Immune Contexture for Optimal Diagnosis and Treatment of Lung Cancer
$722,919Kurt A Schalper · Yale University · R37 · FY2025 · CA
Modulating pathogenic T cells in Type 1 diabetes
$722,908Kevan C Herold · Yale University · R01 · FY2024 · DK
IMPACT OF TUBERCULOSIS OF HIV INFECTION IN UGANDA
$722,886Case Western Reserve University · R01 · FY2003 · AI
Preclinical development of breakthrough immunotherapy for brain tumors
$722,707Hideho Okada · University Of California, San Francisco · R35 · FY2020 · NS
City of Hope Clinical Oncology Career Research Development Program
$722,675Joanne E. Mortimer · Beckman Research Institute/City Of Hope · K12 · FY2009 · CA
IMMUNOTHERAPY FOR NF2 VESTIBULAR SCHWANNOMAS
$722,625The General Hospital Corporation · · FY2016 · Department of the Army
Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy
$722,621Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2023 · CA